HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BB 3103

Also Known As:

BB-3103

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Hydroxamic Acids: 239
      - BB 3103: 4
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Hydroxamic Acids: 239
      - BB 3103: 4

Experts

1.	De Silva, Bernadette: 1 article (10/2002)
2.	Harris, Stephen H: 1 article (10/2002)
3.	Howie, Sarah E M: 1 article (10/2002)
4.	Lamb, Jonathan R: 1 article (10/2002)
5.	Layton, Guy T: 1 article (10/2002)
6.	Rossi, Adriano G: 1 article (10/2002)
7.	Savage, Nigel D L: 1 article (10/2002)
8.	Agren, Magnus S: 1 article (01/2002)
9.	Impola, Ulla: 1 article (01/2002)
10.	Karsdal, Morten A: 1 article (01/2002)

Related Diseases

1.	Hypertrophy 11/01/2001 - "In the present study, we show that hydroxamate-based inhibitors of metalloproteases (HIMPs), such as TAPI and BB-3103, increase the fusion of C(2)C(12) myoblasts and provoke myotube hypertrophy. "
2.	Lung Injury 06/30/1999 - "Attenuation of oxidant-induced lung injury by the synthetic matrix metalloproteinase inhibitor BB-3103."
3.	Wounds and Injuries (Trauma) 01/01/2002 - "BB-3103 abrogated epithelialization (p < 0.001), whereas aprotinin-treated wounds and controls were covered with new epithelium. " 01/01/2002 - "Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo."
4.	Atopic Dermatitis (Atopic Eczema) 10/01/2002 - "Similarly, BB-3103 mediated prolonged inhibition of allergen-dependent peripheral T cell proliferation in atopic dermatitis patients but not in healthy controls. "

Related Drugs and Biologics

1.	Metalloproteases (Metalloproteinases)
2.	Matrix Metalloproteinase Inhibitors
3.	Oxidants (Oxidizing Agents)
4.	Serine Proteinase Inhibitors (Serine Protease Inhibitors)
5.	Aprotinin (Trasylol)
6.	Allergens